For citations:
Pomytkin I.A., Pisarev V.V., Merkulov M.E., Lukinykh L.V., Morzhukhina M.V., Karkischenko N.N. Results of Phase III Clinical Trial: a Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study of the Efficacy and Safety of Direkord in Ischemic Stroke Patients in Early Recovery Period. Journal Biomed. 2023;19(4):81-93. (In Russ.) https://doi.org/10.33647/2074-5982-19-4-81-93
Email this article 
